These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 12806858)
21. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105 [TBL] [Abstract][Full Text] [Related]
22. [Hormone replacement therapy in menopause]. Breckwoldt M Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630 [No Abstract] [Full Text] [Related]
23. HRT and the young at heart. Mendelsohn ME; Karas RH N Engl J Med; 2007 Jun; 356(25):2639-41. PubMed ID: 17582075 [No Abstract] [Full Text] [Related]
24. Estrogen and C-reactive protein: does an alternate route lead to a more attractive destination? Duvernoy C Thromb Haemost; 2003 Jul; 90(1):1-2. PubMed ID: 12876618 [No Abstract] [Full Text] [Related]
28. An unusual cause of recurrent chorea. Caviness JN; Muenter MD Mov Disord; 1991; 6(4):355-7. PubMed ID: 1661846 [TBL] [Abstract][Full Text] [Related]
29. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study. Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192 [TBL] [Abstract][Full Text] [Related]
31. The WHI estrogen-alone trial--do things look any better? Hulley SB; Grady D JAMA; 2004 Apr; 291(14):1769-71. PubMed ID: 15082705 [No Abstract] [Full Text] [Related]
32. [Requiem for hormone replacement therapy? This does not apply to modern preparations!]. Lippert TH; Mueck AO MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434 [No Abstract] [Full Text] [Related]
33. [Treatment with estrogen]. Ingelman-Sundberg A Lakartidningen; 2002 Nov; 99(47):4777-8. PubMed ID: 12523062 [No Abstract] [Full Text] [Related]
34. Importance of the progestogen added to the estrogen in hormone therapy. Lauritzen C Climacteric; 2005 Dec; 8(4):398-400. PubMed ID: 16390775 [No Abstract] [Full Text] [Related]
35. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat. Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153 [TBL] [Abstract][Full Text] [Related]
36. Lower doses of estrogen replacement therapy and the risk of cardiovascular disease. Wakatsuki A Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):e197; author reply e197. PubMed ID: 15576640 [No Abstract] [Full Text] [Related]
37. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy. Twombly R J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368 [No Abstract] [Full Text] [Related]
38. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358 [TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy in postmenopausal women: emerging hope for future. Gambhir DS; Gambhir JK Indian Heart J; 1998; 50(1):19-21. PubMed ID: 9583282 [No Abstract] [Full Text] [Related]